VCM
KMTS

Versant Capital Management’s Kestra Medical Technologies KMTS Stock Holding History

Versant Capital Management’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.03K Buy
237
+208
+717% +$4.36K ﹤0.01% 2392
2026
Q1 		$578 Buy
+29
New +$683 ﹤0.01% 2712

Other funds holding KMTS

FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Versant Capital Management's KMTS Position: Q2 2026 in Review

Versant Capital Management increased its Kestra Medical Technologies (KMTS) stake by 717% in Q2 2026, buying an estimated $4.36K and bringing the position to 237 shares worth $6.03K. The position accounts for ﹤0.01% of the portfolio, ranked #2392.

Versant Capital Management first reported a position in KMTS in Q1 2026 and has held it in 2 quarters since. 4 funds tracked by Wall St. Rank hold KMTS as of Q2 2026.

  • Versant Capital Management held 237 shares of Kestra Medical Technologies worth $6.03K as of Q2 2026.
  • Versant Capital Management bought 208 Kestra Medical Technologies shares in Q2 2026, an estimated $4.36K.
  • Kestra Medical Technologies made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #2392 holding.
  • Versant Capital Management first reported a position in Kestra Medical Technologies in Q1 2026 and has held it in 2 quarters since.
  • 4 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.